HLB Plans OTC Sale of 2,252,252 Convertible Bonds of HLB Genex, Reducing Stake from 19.55% to 14.37%
HLB reported a planned OTC sale of 2,252,252 convertible bonds of its subsidiary HLB Genex.
The sale price is set at the current conversion price of 2,220 KRW per share, totaling 5 billion KRW.
The purpose is to reallocate investment assets to focus on core businesses and maximize asset management efficiency.
After the transaction, HLB's ownership ratio of HLB Genex's specific securities will decrease from 19.55% to 14.37%, while its common stock ownership remains unchanged at 8.02%.
The conversion price of 2,220 KRW is 12.6% higher than the current stock price of 1,972 KRW, reducing the likelihood of immediate conversion.
[AI Summary]HLB's planned sale of HLB Genex convertible bonds signals reduced control and may negatively impact the stock price, but the OTC sale does not trigger immediate dilution and the capital reallocation purpose is neutral.
KOSDAQ Filing Information
Report On Transaction Plan Of Specific Securities By Executives And Major Shareholders